Numinus Wellness (CVE: NUMI) CEO Payton Nyquvest joined Steve Darling from Proactive to bring news the company has filed for patent protection for their sustainable, reproducible and easily scalable process to rapidly generate therapeutic products from psychoactive fungi species that contain psilocybin, other psychoactive compounds.
Nyquvest telling Proactive the company tested the production process to rapidly generate a Psilocybe species extract as ‘proof of concept’. The results revealed a highly efficient, scalable process that can be applied to other species of psychoactive fungi.